Medicines Co. (MDCO) Misses Q1 EPS by 20c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. NDAQ

Go back to Medicines Co. (MDCO) Misses Q1 EPS by 20c

The Medicines Company Reports First-Quarter 2017 Financial Results

April 26, 2017 7:16 AM EDT

PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ: MDCO) today announced its business and financial results for the first-quarter ended March 31, 2017.

During the first quarter of 2017, The Medicine Company continued to deliver excellent execution against our 2017 objectives, significantly advancing key development programs, strictly managing cash deployment to enhance our ability to support our products and pipeline going forward, maintaining maximum strategic and operational flexibility and positioning us to drive shareholder value, said Clive Meanwell, M.D., Ph.D., Chief Executive Officer of The Medicines Company. Nowhere is that execution excellence... More